LIN SHAO-LEE (CHIEF EXECUTIVE OFFICER) received a stock award from CUE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/10/2026ACC: 0001725092-26-000006
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2026
+655.07K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
655.07K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+327.54K
Price / share
—
Trade value
—
% of position
100.0%
7/9/2026
327.54K→655.07K
Total
Net shares
+327.54K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2026 | A · Award | +327.54K | — | — | 100.0% | 327.54K | 655.07K |
| Total | +327.54K | $0.00 | ||||||
Derivative Transactions1
Common Stock
Direct
Converts to
Common Stock
327.54K shares
Shares
+327.54K
Strike price
Held after
327.54K
Exercisable
—
7/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Direct | Common Stock327.54K shares | 7/9/2026 | A · Award | +327.54K | — | 327.54K |